πŸ‡ΊπŸ‡Έ FDA
Patent

US 9149539

Crystalline naloxol-PEG conjugate

granted A61KA61K47/60A61P

Quick answer

US patent 9149539 (Crystalline naloxol-PEG conjugate) held by Nektar Therapeutics expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K47/60, A61P, A61P25/00, A61P25/04